Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-07 13:59:25 - browse：226

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Opioid cravings were reduced by anti

knowledge

WSS

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Weight loss drugs aren’t covered by Obamacare. That may change

As AI regulations shape up, health tech startups beg for clarity

The high personal cost of affirmative action for Black doctors

explore

Wikipedia

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Ukraine seeks to reclaim its role as a hub for clinical trials

Novavax promises a turnaround & Lilly roils the obesity market

Surprise medical billing ban raises prices elsewhere

After affirmative action ruling, medical educators look to 'holistic review'

‘Oppenheimer’ and the risks of AI in health care

Sports medicine is finally prioritizing gender equality

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Cancer drug shortages should be causing more outrage

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

knowledge

Scientists inch closer to single

In 'major milestone,' FDA approves first cell therapy for solid tumors

What the US credit downgrade means for the economy, your finances

Abridge raises $150m as clinical notes automation market heats up

MD Anderson's Padmanee Sharma responds to research credit suit

Abridge raises $150m as clinical notes automation market heats up

explore

leisure time

knowledge

entertainment